Rare lephants
Screener

NanoViricides, Inc.

NNVC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-3 Mar 1, 2017 FORM S-3
10-Q Feb 14, 2017 FORM 10-Q
8-K Feb 13, 2017 FORM 8-K
4 Feb 3, 2017 OWNERSHIP DOCUMENT
8-K Dec 15, 2016 FORM 8-K
10-Q Nov 14, 2016 FORM 10-Q
DEF 14A Oct 28, 2016 DEF 14A
10-K Sep 16, 2016 FORM 10-K
4 May 24, 2016 OWNERSHIP DOCUMENT
4 May 18, 2016 OWNERSHIP DOCUMENT
10-Q May 10, 2016 FORM 10-Q
4 May 5, 2016 OWNERSHIP DOCUMENT
4 May 2, 2016 OWNERSHIP DOCUMENT
EFFECT Apr 14, 2016
POS AM Apr 7, 2016 POS AM
4 Feb 24, 2016 OWNERSHIP DOCUMENT
4 Feb 16, 2016 OWNERSHIP DOCUMENT
10-Q Feb 9, 2016 FORM 10-Q
8-K Jan 29, 2016 8-K
DEF 14A Dec 8, 2015 DEF 14A
4 Nov 17, 2015 OWNERSHIP DOCUMENT
10-Q Nov 9, 2015 FORM 10-Q
4 Oct 23, 2015 OWNERSHIP DOCUMENT
4 Sep 24, 2015 FORM 4
4 Sep 24, 2015 FORM 4
← Newer Page 9 of 23 · 556 filings Older →